Methods and means for determining treatment of subjects with exogenous somatotropin

N.G.E. Smits; M.H. Blokland; M.W.F. Nielen

Methods and means for determining treatment of subjects with exogenous somatotropin

N.G.E. Smits (Inventor), M.H. Blokland (Inventor), M.W.F. Nielen (Inventor)

Research output: Patent

Abstract

Described are methods for determining whether a subject has been treated with exogenous somatotropin. The disclosure further relates to kits for determining whether a subject has been treated with exogenous somatotropin, and to the use of such kits for determining whether a subject has been treated with exogenous somatotropin.

Original language	English
Patent number	US2017354717
Priority date	9/06/16
Publication status	Published - 14 Dec 2017

Access to Document

https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=2017354717A1&KC=A1&FT=D&ND=3&date=20171214&DB=EPODOC&locale=en_EP

Cite this

@misc{53474205d54b453db0f0b0f53b165010,

title = "Methods and means for determining treatment of subjects with exogenous somatotropin ",

abstract = "Described are methods for determining whether a subject has been treated with exogenous somatotropin. The disclosure further relates to kits for determining whether a subject has been treated with exogenous somatotropin, and to the use of such kits for determining whether a subject has been treated with exogenous somatotropin.",

author = "N.G.E. Smits and M.H. Blokland and M.W.F. Nielen",

year = "2017",

month = dec,

day = "14",

language = "English",

type = "Patent",

note = "US2017354717",

}

TY - PAT

T1 - Methods and means for determining treatment of subjects with exogenous somatotropin

AU - Smits, N.G.E.

AU - Blokland, M.H.

AU - Nielen, M.W.F.

PY - 2017/12/14

Y1 - 2017/12/14

N2 - Described are methods for determining whether a subject has been treated with exogenous somatotropin. The disclosure further relates to kits for determining whether a subject has been treated with exogenous somatotropin, and to the use of such kits for determining whether a subject has been treated with exogenous somatotropin.

AB - Described are methods for determining whether a subject has been treated with exogenous somatotropin. The disclosure further relates to kits for determining whether a subject has been treated with exogenous somatotropin, and to the use of such kits for determining whether a subject has been treated with exogenous somatotropin.

M3 - Patent

M1 - US2017354717

ER -

Methods and means for determining treatment of subjects with exogenous somatotropin

Abstract

Access to Document

Fingerprint

Cite this